Want to join the conversation?
$IDTI's cash and short-term investments decreased approx. $4MM to $351MM. Free cash flow for 1Q17 was approx. $23MM and free cash flow as a percent of revenue was 26% on a trailing 4-quarter basis. The company spent $30.6MM to repurchase 1.5MM shares at an average price of $20.90.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.